ENXTPA:SANPharmaceuticals
Sanofi Brings Back Veteran Leader As Market Weighs R&D And Valuation
Sanofi (ENXTPA:SAN) announced that its Board of Directors will not renew CEO Paul Hudson's mandate.
Belén Garijo, former Merck KGaA CEO and previous Sanofi executive, has been appointed as the incoming CEO.
The leadership change comes at a time of R&D, productivity, and US vaccine business challenges for the company.
Sanofi sits at the crossroads of big pharma and vaccines, with investors watching closely as it responds to recent pipeline setbacks and pressure in its US vaccine operations...